Form 4: Hologic Executive Acquires 15,196 Shares

Hologic's Group President, International, Jan Verstreken, acquired 15,196 shares of common stock through the vesting of performance stock units.

Summary

• Jan Verstreken, Group President, International at Hologic Inc. (HOLX), acquired 15,196 shares of common stock.
• The transaction occurred on November 4, 2025.
• These shares represent performance stock units for which the performance criteria have been satisfied, though they remain subject to service-based vesting requirements.
• Performance stock units are settled in shares of common stock on a one-for-one basis.
• Following this acquisition, Mr. Verstreken beneficially owns a total of 119,010 shares of Hologic Inc. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive, resulting from the satisfaction of performance criteria for stock units, generally indicates positive internal sentiment and increased alignment with shareholder interests. It is a routine, positive event.

Positives

• A key executive increased their beneficial ownership in the company, further aligning their interests with shareholders.
• The acquisition resulted from the vesting of performance stock units, indicating that pre-defined performance criteria were successfully met.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transaction increases the alignment of a key executive's financial interests with those of the shareholders.
• Employees: May signal confidence in the company's performance and the effectiveness of its executive compensation structure.

Key Dates

Recommendation

The filing reports a routine executive stock acquisition through the vesting of performance stock units, which is a neutral to slightly positive event indicating performance criteria were met and increasing executive alignment. It does not present new information significant enough to alter an existing investment thesis or recommendation.

Keywords

Hologic, HOLX, insider transaction, Form 4, stock acquisition, executive compensation, performance stock units, Jan Verstreken